Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Hydroxypyrimidine, also known as Pyrimidone, is a heterocyclic compound with the formula C4H4N2O. It is one of the two isomers, 2-pyrimidone and 4-pyrimidone, which can be referred to as 2-hydroxypyrimidine or 4-hydroxypyrimidine based on the substituted pyrimidine or 1,3-diazine ring. 4-Hydroxypyrimidine is an important bioactive molecule that exhibits various biological activities, including anti-viral, anti-tumor, induction of interferon production, and immune regulation. It appears as a white to slightly yellow powder.

51953-17-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 51953-17-4 Structure
  • Basic information

    1. Product Name: 4-Hydroxypyrimidine
    2. Synonyms: 3,4-dihydropyriMidin-4-one;4(3H)-PyriMidone, 98+% 10GR;4(3H)-PyriMidinone, 98+%;4(1H)-PYRIMIDINONE;4(3H)-PYRIMIDINONE;4(3H)-PYRIMIDONE;4-PYRIMIDINONE;4-PYRIMIDONE
    3. CAS NO:51953-17-4
    4. Molecular Formula: C4H4N2O
    5. Molecular Weight: 96.09
    6. EINECS: 224-932-4
    7. Product Categories: Pyrimidine series;Building Blocks;Heterocyclic Building Blocks;Pyrimidines;PYRIMIDINE;Heterocycles
    8. Mol File: 51953-17-4.mol
  • Chemical Properties

    1. Melting Point: 166-169 °C(lit.)
    2. Boiling Point: 179.58°C (rough estimate)
    3. Flash Point: 91.227 °C
    4. Appearance: White to slightly yellow/Powder
    5. Density: 1.2604 (rough estimate)
    6. Vapor Pressure: 0.725mmHg at 25°C
    7. Refractive Index: 1.4610 (estimate)
    8. Storage Temp.: 0-6°C
    9. Solubility: N/A
    10. PKA: pK1:1.85(+1);pK2:8.59(0) (25°C)
    11. Water Solubility: 270.3g/L(20 oC)
    12. BRN: 106975
    13. CAS DataBase Reference: 4-Hydroxypyrimidine(CAS DataBase Reference)
    14. NIST Chemistry Reference: 4-Hydroxypyrimidine(51953-17-4)
    15. EPA Substance Registry System: 4-Hydroxypyrimidine(51953-17-4)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 22-24/25-37/39-26-36
    4. WGK Germany: 3
    5. RTECS: UW7350100
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 51953-17-4(Hazardous Substances Data)

51953-17-4 Usage

Uses

Used in Pharmaceutical Industry:
4-Hydroxypyrimidine is used as an active pharmaceutical ingredient for its anti-viral, anti-tumor, and immune-regulating properties. It plays a crucial role in the development of drugs targeting various diseases, including cancer and viral infections.
Used in Biochemical Research:
In the field of biochemical research, 4-Hydroxypyrimidine serves as a valuable compound for studying its biological activities and potential applications in drug development. Researchers utilize this molecule to investigate its interactions with other biomolecules and its effects on cellular processes.
Used in Drug Synthesis:
4-Hydroxypyrimidine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with improved efficacy and reduced side effects.
Used in Diagnostic Applications:
Due to its biological activities, 4-Hydroxypyrimidine can be employed in the development of diagnostic tools and tests for detecting specific diseases or conditions, particularly those related to viral infections and cancer.

Enzyme inhibitor

This hygroscopic pyrimidine, also known as 4-hydroxypyrimidine and 4- pyrimidinol (FW = 96.09 g/mol), inhibits both hypoxanthine(guanine) and xanthine phosphoribosyltransferases.

Check Digit Verification of cas no

The CAS Registry Mumber 51953-17-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,5 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51953-17:
(7*5)+(6*1)+(5*9)+(4*5)+(3*3)+(2*1)+(1*7)=124
124 % 10 = 4
So 51953-17-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H4N2O/c7-4-1-2-5-3-6-4/h1-3H,(H,5,6,7)

51953-17-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10859)  4(3H)-Pyrimidinone, 98%   

  • 51953-17-4

  • 1g

  • 218.0CNY

  • Detail
  • Alfa Aesar

  • (A10859)  4(3H)-Pyrimidinone, 98%   

  • 51953-17-4

  • 5g

  • 1056.0CNY

  • Detail

51953-17-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Hydroxypyrimidine

1.2 Other means of identification

Product number -
Other names pyrimidin-4-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51953-17-4 SDS

51953-17-4Relevant articles and documents

IR SPECTRA AND PHOTOTAUTOMERISM OF MATRIX ISOLATED 4-OXOPYRIMIDINE

Nowak, M. J.,Fulara, J.,Lapinski, L.

, p. 91 - 96 (1988)

Uv-light induced intramolecular proton-transfer was observed in matrix isolated 4-oxopyrimidine, 2-pyridone and hypoxanthine.Mixed spectrum of 4-oxo- and 4-hydroxy-pyrimidine in Ar and Ne matrices was unambiguously partitioned into the two sets of peaks corresponding to the two tautomers.Both spectra were compared to the spectra in the solid phases and interpreted.

Ab initio calculations of IR spectra in identification of products of matrix isolation photochemistry. Dewar form of 4(3H)-pyrimidinone

Lapinski,Nowak,Les,Adamowicz

, p. 1461 - 1467 (1994)

Ab initio calculations of the infrared spectrum of the Dewar isomer of 3-methyl-4(3H)-pyrimidinone have been carried out at the MP2/6-31G and SCF/6-31G levels of theory. These were compared with the experimental spectrum of the photoproduct that emerged upon UV (308 nm) irradiation of 3-methyl-4(3H)-pyrimidinone isolated in a low-temperature argon matrix. The agreement between the spectrum simulated at the MP2 level and the experimental spectrum was remarkable and enabled positive assignment of the photoproduct structure. Photoreactions of matrix-isolated 4(3H)-pyrimidinones not methylated at the N3 nitrogen atom have also been studied. For these compounds, three types of photoreactions were observed, i.e., phototautomerism, ring opening, and Dewar structure formation. The relative probabilities of the three competing reaction directions and their dependencies on ring substitutions have been investigated, and results are presented.

Thermal Behavior Analysis of Two Synthesized Flavor Precursors of N-alkylpyrrole Derivatives

Ai, Lvye,Liu, Mengzhen,Ji, Xiaoming,Lai, Miao,Zhao, Mingqin,Ren, Tianbao

, p. 2389 - 2397 (2019/08/01)

To expand the library of pyrrole-containing flavor precursors, two new flavor precursors—methyl N-benzyl-2-methyl-5-formylpyrrole-3-carboxylate (NBMF) and methyl N-butyl-2-methyl-5-formylpyrrole-3-carboxylate (NUMF)—were synthesized by cyclization, oxidation, and alkylation reactions. Thermogravimetry (TG), differential scanning calorimeter, and pyrolysis–gas chromatography/mass spectrometry were utilized to analyze the thermal degradation behavior and thermal degradation products of NBMF and NUMF. The TG-DTG curve indicated that the maximum mass loss rates of NBMF and NUMF appear at 310 and 268°C, respectively. The largest peaks of NBMF and NUMF showed by the differential scanning calorimeter curve were 315 and 274°C, respectively. Pyrolysis–gas chromatography/mass spectrometry detected small molecule fragrance compounds appeared during thermal degradation, such as 2-methylpyrrole, 1-methylpyrrole-2-carboxylic acid methyl ester, limonene, and methyl formate. Finally, the thermal degradation mechanism of NBMF and NUMF was discussed, which provided a theoretical basis for their application in tobacco flavoring additives.

1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF

-

Example 32, (2010/01/30)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer'disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R 1, R 3, R 4, R 5, Z, Y, V, X, X', J, K, L, and M are as defined herein.

1N-alkyl-N-arylpyrimidinamines and derivatives thereof

-

, (2008/06/13)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R1, R3, R4, R5, Z, Y, V, X, X', J, K, L, and M are as defined herein.

Combined matrix-isolation FT-IR and ab initio 6-31++G** study of H-bonded complexes between water and molecules modelling cytosine or isocytosine

Smets, Johan,Adamovicz, Ludwik,Maes, Guido

, p. 113 - 130 (2007/10/02)

A step-by-step experimental and ab initio SCF/6-31++G** procedure is described for the interpretation of the matrix FT-IR spectra of H-bonded complexes of cytosine or isocytosine with water.The method involves a detailed study of several compounds, each modelling one or a few cytosine sites and/or tautomers in order of increasing complexity.Results are presented for tautomerization processes in 2-OH-pyridine, 4-OH-pyrimidine and isocytosine, and for H-bonded complexes of water with pyrimidine, 4-OH-pyridine and 4-NH2-pyridine.The whole series of obtained results has allowed the setting up of a large-scale vibration correlation diagram for water complexed with N- and O-bases.It also allows some new, important conclusions to be drawn about the major problem of scaling ab initio predicted frequencies for anharmonic proton-donor vibrational modes.

Dual Fluorescence of 4-(Dialkylamino)pyrimidines. Twisted Intramolecular Charge Transfer State Formation Favored by Hydrogen Bond or by Coordination to the Metal Ion

Herbich, Jerzy,Grabowski, Zbigniew R.,Wojtowicz, Hanna,Golankiewicz, Krzysztof

, p. 3439 - 3444 (2007/10/02)

4-(N,N-dimethylamino)pyrimidine (4-DMAP) does not exhibit any markedly dual luminescence even in highly polar (aprotic) solvents, unless the ortho substituent deviates the amino group from coplanarity with the ring.Protic solvents or complexation with Zn2+ cause the long-wave fluorescence to appear distinctly.Contrary to 4-DMAP, 4-(N,N-diethylamino)pyrimidine (4-DEAP) reveals dual luminescence in sufficiently polar (aprotic) environment.In alcoholic solutions the intensity of the fluorescence is drastically reduced.Fluorescence properties of this group of compounds fit well to the TICT modell.The importance of nonradiative deactivation increases with the proton-donating ability of the solvent.

Theoretical Description of Solvent Effects. V. The Medium Influence on the Lactim-Lactam Tautomerism of Hydroxyazines

Krebs, C.,Foerster, W.,Weiss, C.,Hofmann, H.-J.

, p. 369 - 378 (2007/10/02)

Der Loesungsmitteleffekt auf die Tautomeriegleichgewichte der Titelverbindungen wird mit Hilfe klassischer und quantenchemischer Versionen der Solvatonen- und der Reaktionsfeldtheorie berechnet.In Uebereinstimmung mit dem Experiment ergeben alle getesteten Verfahren eine Gleichgewichtsverschiebung zugunsten der Lactamform.Zur quantitativen Beschreibung dieses Effektes ist jedoch das Reaktionsfeldmodell besser geeignet.

EQUILIBRE LACTIME-LACTAME DES HYDROXY-PYRIDINES ET DES HYDROXY-PYRIMIDINES (URACILES) EN MILIEU APOLAIRE: ETUDE INFRA-ROUGE

Chevrier, Marianne,Bensaude, Olivier,Guillerez, Jean,Dubois, Jacques-Emile

, p. 3359 - 3362 (2007/10/02)

In contrast to what observed with mono hydroxy-pyridines and -pyrimidines the lactim-lactam equilibrium of uracils is not found to be markedly influenced by solvent polarity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51953-17-4